V. S. Kalyanaraman

Immunology and Microbiology · Life Sciences

34h-index4.9kcitations74works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(38), T-cell and Retrovirus Studies(31), Animal Disease Management and Epidemiology(26), Vector-Borne Animal Diseases(20), Virus-based gene therapy research(11)

Publications74 total

A STUDY TO CLASSIFY THE FINE NEEDLE ASPIRATES OF BREAST LUMPS AS PER THE IAC YOKOHAMA SYSTEM FOR REPORTING BREAST PATHOLOGY IN THANJAVUR MEDICAL COLLEGE
PARIPEX INDIAN JOURNAL OF RESEARCH·2025Open Access
Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge
PLoS Pathogens·2015· 56 citedOpen Access
C1 Evaluation of Novel HIV Envelopes in Rabbits Immunized With a DNA Prime/Protein Boost Vaccine Regimen
JAIDS Journal of Acquired Immune Deficiency Syndromes·2012
Sequential Priming with Simian Immunodeficiency Virus (SIV) DNA Vaccines, with or without Encoded Cytokines, and a Replicating Adenovirus-SIV Recombinant Followed by Protein Boosting Does Not Control a Pathogenic SIV<sub>mac251</sub>Mucosal Challenge
Journal of Virology·2008· 37 citedOpen Access
Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: Influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV89.6P infection
Vaccine·2008· 41 citedOpen Access
Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A⁎01 negative rhesus macaques
Virology·2008· 28 cited
Comparative evaluation of oral and intranasal priming with replication-competent adenovirus 5 host range mutant (Ad5hr)-simian immunodeficiency virus (SIV) recombinant vaccines on immunogenicity and protective efficacy against SIVmac251
Vaccine·2007· 48 cited
A Replication-Competent Adenovirus-Human Immunodeficiency Virus (Ad-HIV)<i>tat</i>and Ad-HIV<i>env</i>Priming/Tat and Envelope Protein Boosting Regimen Elicits Enhanced Protective Efficacy against Simian/Human Immunodeficiency Virus SHIV<sub>89.6P</sub>Challenge in Rhesus Macaques
Journal of Virology·2007· 81 citedOpen Access
Non-neutralizing antibodies and vaccine-induced protection
Retrovirology·2006· 8 citedOpen Access
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E
Virology·2006· 112 cited
Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype
Virology·2006· 94 cited
Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag
Virology·2005· 26 cited
Polyvalent DNA prime and envelope protein boost HIV‐1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate
Journal of Medical Primatology·2005· 57 citedOpen Access
Replicating Rather than Nonreplicating Adenovirus-Human Immunodeficiency Virus Recombinant Vaccines Are Better at Eliciting Potent Cellular Immunity and Priming High-Titer Antibodies
Journal of Virology·2005· 109 citedOpen Access
Protection against Mucosal Simian Immunodeficiency Virus SIV <sub>mac251</sub> Challenge by Using Replicating Adenovirus-SIV Multigene Vaccine Priming and Subunit Boosting
Journal of Virology·2004· 172 citedOpen Access
Evaluation of Combination DNA/Replication-Competent Ad-SIV Recombinant Immunization Regimens in Rhesus Macaques
AIDS Research and Human Retroviruses·2004· 12 cited
Improved Protection of Rhesus Macaques against Intrarectal Simian Immunodeficiency Virus SIV<sub>mac251</sub>Challenge by a Replication-Competent Ad5hr-SIV<i>env</i>/<i>rev</i>and Ad5hr-SIV<i>gag</i>Recombinant Priming/gp120 Boosting Regimen
Journal of Virology·2003· 48 citedOpen Access
Design and In Vivo Immunogenicity of a Polyvalent Vaccine Based on SIVmac Regulatory Genes
DNA and Cell Biology·2002· 9 cited
Crosslinked HIV-1 envelope–CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques
Proceedings of the National Academy of Sciences·2002· 108 citedOpen Access
A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice
Proceedings of the National Academy of Sciences·2002· 31 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Marjorie Robert-Guroff(17), Robert C. Gallo(12), David Venzon(9), Ranajit Pal(9), David C. Montefiori(8), L. Jean Patterson(7), M. G. Sarngadharan(7), Phillip D. Markham(6), Thorsten Demberg(5), M Popovic(4), Genoveffa Franchini(4), Raúl Gómez Román(4), Barbara Ensoli(4), B.C. Nair(4), Bo Peng(4), Irene Kalisz(4), Eun Mi Lee(4), William A. Blattner(3), M S Reitz(3), M. G. Sarngadharan(3)